The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy, in R/R multiple myeloma (MM) patients: Updated results of a first-in-human (FIH) phase I dose escalation study.
 
Max S. Topp
Honoraria - Amgen
Consulting or Advisory Role - Affimed Therapeutics; Amgen; Gilead Sciences; Jazz Pharmaceuticals; Regeneron; Roche
Speakers' Bureau - Amgen
Research Funding - Affimed Therapeutics; Amgen; Regeneron; Roche
Patents, Royalties, Other Intellectual Property - Biomarkers for Immunotherapies
Expert Testimony - Affimed Therapeutics; Amgen; Boehringer Ingelheim; Regeneron
Travel, Accommodations, Expenses - Affimed Therapeutics; Amgen; Roche
 
Johannes Duell
No Relationships to Disclose
 
Gerhard Zugmaier
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Michel Attal
No Relationships to Disclose
 
Philippe Moreau
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Christian Langer
No Relationships to Disclose
 
Jan Kroenke
Speakers' Bureau - Amgen
 
Thierry Facon
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Speakers' Bureau - celgene; Janssen; Takeda
 
Alexey Salnikov
Employment - Boehringer Ingelheim
 
Robin Lesley
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Karl Beutner
No Relationships to Disclose
 
James Kalabus
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Erik Rasmussen
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Kathrin Riemann
Employment - Boehringer Ingelheim
 
Alex C. Minella
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Gerd Michael Munzert
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim
 
Hermann Einsele
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda